Y.D. More Investments Ltd Lowers Stock Holdings in Nutrien Ltd. (NYSE:NTR)

Y.D. More Investments Ltd trimmed its stake in Nutrien Ltd. (NYSE:NTR) by 21.6% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,746 shares of the company’s stock after selling 480 shares during the period. Y.D. More Investments Ltd’s holdings in Nutrien were worth $98,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors also recently added to or reduced their stakes in NTR. The Manufacturers Life Insurance Company raised its holdings in shares of Nutrien by 51.3% in the 3rd quarter. The Manufacturers Life Insurance Company now owns 6,853,165 shares of the company’s stock valued at $425,881,000 after purchasing an additional 2,322,679 shares in the last quarter. ANTIPODES PARTNERS Ltd raised its holdings in shares of Nutrien by 18,312.9% in the 4th quarter. ANTIPODES PARTNERS Ltd now owns 1,595,295 shares of the company’s stock valued at $89,862,000 after purchasing an additional 1,586,631 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd raised its holdings in shares of Nutrien by 544.3% in the 3rd quarter. Clal Insurance Enterprises Holdings Ltd now owns 1,361,282 shares of the company’s stock valued at $84,794,000 after purchasing an additional 1,150,000 shares in the last quarter. TD Asset Management Inc raised its holdings in shares of Nutrien by 15.0% in the 3rd quarter. TD Asset Management Inc now owns 7,175,994 shares of the company’s stock valued at $445,187,000 after purchasing an additional 933,517 shares in the last quarter. Finally, FMR LLC raised its stake in shares of Nutrien by 15.4% during the 3rd quarter. FMR LLC now owns 6,369,027 shares of the company’s stock worth $393,325,000 after acquiring an additional 849,908 shares in the last quarter. 63.10% of the stock is owned by hedge funds and other institutional investors.

Nutrien Price Performance

Nutrien stock opened at $52.86 on Thursday. Nutrien Ltd. has a 12-month low of $47.90 and a 12-month high of $69.55. The stock has a market cap of $26.14 billion, a P/E ratio of 20.75, a PEG ratio of 1.97 and a beta of 0.89. The company has a 50-day moving average price of $53.38 and a 200 day moving average price of $53.88. The company has a current ratio of 1.17, a quick ratio of 0.65 and a debt-to-equity ratio of 0.35.

Nutrien (NYSE:NTR) last released its quarterly earnings data on Wednesday, February 21st. The company reported $0.37 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.72 by ($0.35). The firm had revenue of $5.66 billion for the quarter, compared to analyst estimates of $5.36 billion. Nutrien had a return on equity of 8.59% and a net margin of 4.33%. Nutrien’s revenue for the quarter was down 24.8% on a year-over-year basis. During the same quarter in the previous year, the business posted $2.02 earnings per share. Sell-side analysts anticipate that Nutrien Ltd. will post 3.82 earnings per share for the current year.

Nutrien Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, April 11th. Shareholders of record on Thursday, March 28th were paid a dividend of $0.54 per share. This represents a $2.16 annualized dividend and a yield of 4.09%. The ex-dividend date was Wednesday, March 27th. This is a positive change from Nutrien’s previous quarterly dividend of $0.53. Nutrien’s dividend payout ratio (DPR) is 85.38%.

Analyst Upgrades and Downgrades

Several research analysts recently commented on NTR shares. Wells Fargo & Company reduced their price objective on shares of Nutrien from $77.00 to $69.00 and set an “overweight” rating for the company in a research note on Monday, February 26th. The Goldman Sachs Group cut their price target on shares of Nutrien from $88.00 to $78.00 and set a “buy” rating on the stock in a research note on Thursday, February 1st. CIBC cut their price target on shares of Nutrien from $87.00 to $76.00 and set an “outperform” rating on the stock in a research note on Friday, February 23rd. BMO Capital Markets lowered their price target on shares of Nutrien from $86.00 to $80.00 and set an “outperform” rating on the stock in a report on Thursday, January 25th. Finally, Raymond James downgraded shares of Nutrien from an “outperform” rating to a “market perform” rating and lowered their price target for the stock from $80.00 to $65.00 in a report on Friday, January 12th. Two equities research analysts have rated the stock with a sell rating, five have issued a hold rating and twelve have issued a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $68.25.

Nutrien Profile

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.